Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin®), fast-acting lispro injection (Prandilin™), fast-acting ...

Lilly announced a shortage of Lispro in March. Patients say it is still ongoing ... months after cutting its price by 65% to ...

Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...

WASHINGTON (Reuters) - Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a major accomplishment of the Biden administration ...

The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...

Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter vials. The company said new regulations had led to a brief delay in manufacturing ...

Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply ... products and more than 800 million insulin pens a year. "Not only are we not winding down our work ...